- Fund Information
Invesco Dynamic Biotechnology & Genome ETF: (PBE)
(Delayed Data from NYSE) As of Mar 26, 2019 03:58 PM ET
$54.74 USD
+0.86 (1.59%)
Volume: 6,098
Zacks ETF Rank 3 - Hold 3
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
| Zacks Rank | Definition |
|---|---|
| 1 | Strong Buy |
| 2 | Buy |
| 3 | Hold |
| 4 | Sell |
| 5 | Strong Sell |
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Quote Details
| Previous Close | 53.88 |
| Open | 54.30 |
| Bid | 51.46 |
| Ask | 58.50 |
| Day Low-High | 54.25-54.76 |
| 52wk Low-High | 43.17-60.49 |
| Volume | 6,098 |
| NAV (month end) | 54.83 |
| Premium (+)/Discount (-) (month end) | -0.95 |
ETF Expense Ratio
| Expense Ratio | 0.59% |
| Dividend (Yield) | $0.00 (0.00%) |
| Issuer | INVESCO |
Benchmark for PBE
DYNAMIC BIOTECHNOLOGY-GENOME INTELLIDEX
This is comprised of stocks of 30 U.S. biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.
Fund Summary for PBE
INVESCO DYNMC BIOTECHNOLOGY & GENOME ETF
The Invesco Dynamic Biotechnology & Genome ETF is based on the Dynamic Biotech & Genome Intellidex Index.

